ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,144 | -99.9% | 54,901 | -10.1% | 0.00% | 0.0% |
| Q2 2022 | $861,000 | +164.1% | 61,099 | +901.6% | 0.00% | – |
| Q4 2020 | $326,000 | -94.5% | 6,100 | -95.8% | 0.00% | -100.0% |
| Q3 2020 | $5,930,000 | -57.2% | 143,761 | -49.8% | 0.01% | -65.4% |
| Q2 2020 | $13,869,000 | +894.9% | 286,134 | +767.1% | 0.03% | +550.0% |
| Q1 2020 | $1,394,000 | -95.0% | 33,000 | -94.9% | 0.00% | -93.8% |
| Q4 2019 | $27,689,000 | – | 647,248 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |